5

Vivo Bio Tech Ltd

VIVOBIOTECHLTD NSE

Key Fundamentals

MicrocapBiotechnologyHealthcare
Market Cap
₹51.94 Cr
Volatility
Moderate
P/E Ratio
-17.8
EBITDA
₹20.84 Cr
Return on Equity
9.35%
Debt to Equity
0.72
Book Value
₹41.25
EPS
₹1.71
52W High
₹43.35
52W Low
₹20.35

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vivo Bio Tech Ltd insights

29 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Stock is trading at 0.55 times its book value

Weaknesses

5
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -4.81%
  • The company has delivered a poor sales growth of 0.59% over past five years.
  • Promoter holding is low: 30.6%
  • Company has a low return on equity of 2.24% over last 3 years.

Growth Rate

Revenue Growth
3.55% ↗
Net Income Growth
-45.21% ↘
Cash Flow Change
-23.78% ↘
ROE
101.51% ↗
ROCE
18.36% ↗
EBITDA Margin (Avg.)
-21.19% ↘

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
11.58
9.26
12.85
11.76
10.13
12.04
12.21
12.29
12.51
13.11
13.51
14.2
14.28
Expenses
7.09
4.4
6.48
6.39
5.77
6.45
6.67
7.27
7.03
7.69
8.02
9.75
9.23
Operating Profit
4.49
4.86
6.37
5.37
4.36
5.59
5.54
5.02
5.48
5.42
5.49
4.45
5.05
OPM %
38.77%
52.48%
49.57%
45.66%
43.04%
46.43%
45.37%
40.85%
43.8%
41.34%
40.64%
31.34%
35.36%
Other Income
0
0
0.03
0.01
0.01
4.63
0.01
0.15
0.14
0.13
0.14
0.03
0.06
Interest
1.95
2.09
2.22
1.52
1.92
2.06
1.84
1.68
1.5
1.47
1.4
1.48
1.24
Depreciation
2.29
2.3
2.28
2.43
2.23
2.29
2.25
2.25
2.64
2.57
2.66
2.75
3.53
PBT
0.25
0.47
1.9
1.43
0.22
5.87
1.46
1.24
1.48
1.51
1.57
0.25
0.34
Tax %
44%
29.79%
31.05%
48.95%
27.27%
10.73%
43.84%
14.52%
9.46%
42.38%
20.38%
2164%
44.12%
Net Profit
0.14
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
-5.16
0.19
EPS in Rs
0.09
0.22
0.89
0.5
0.11
3.51
0.51
0.62
0.67
0.39
0.57
-2.33
0.09
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17.79
28.58
34.13
47
55.83
55.35
51.78
51.39
52.23
45.45
46.67
53.33
55.1
Expenses
14.99
24.87
26.51
36.11
46.32
42.88
33.98
35.3
30.39
24.19
26.11
32.48
34.69
Operating Profit
2.8
3.71
7.62
10.89
9.51
12.47
17.8
16.09
21.84
21.26
20.56
20.85
20.41
OPM %
15.74%
12.98%
22.33%
23.17%
17.03%
22.53%
34.38%
31.31%
41.82%
46.78%
44.05%
39.1%
37.04%
Other Income
0.95
0.89
0.4
0.13
0.01
0.05
0.08
0.1
0.04
0.04
4.8
0.44
0.36
Interest
0.51
0.47
1.29
2.37
2.64
3.1
3.67
4.27
7.99
7.95
7.55
5.85
5.59
Depreciation
3.05
3.35
3.9
4.64
5.06
5.17
5.59
7.45
9.27
9.29
9.02
10.63
11.51
PBT
0.19
0.78
2.83
4.01
1.82
4.25
8.62
4.47
4.62
4.06
8.79
4.81
3.67
Tax %
-142.11%
-16.67%
11.66%
21.95%
-23.08%
-4.47%
34.11%
50.78%
42.64%
37.93%
17.18%
135.55%
—
Net Profit
0.46
0.91
2.5
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
-1.71
-2.85
EPS in Rs
0.49
0.97
2.67
3.17
1.82
3.45
4.23
1.54
1.78
1.7
4.24
-0.77
-1.28
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9.35
9.35
9.35
9.85
12.35
12.89
13.42
14.26
14.9
14.9
17.16
22.19
Reserves
-0.18
0.71
3.22
9.46
14.92
20.14
29.11
32.87
36.97
39.5
60.74
70.97
Borrowings
5.69
16.91
27.06
25.12
21.68
24.37
30.96
67.44
62.39
73.06
54.03
67.38
Other Liabilities
26.57
18.69
11.49
15.08
6.37
6.29
6.03
7.91
8.77
9.67
11.3
17.89
Total Liabilities
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Fixed Assets
19.69
23.54
28.57
27.66
30.01
34.99
52.05
95.17
88.87
80.37
88.24
123
CWIP
0.07
0.04
2.96
3.94
0.07
0.15
0.32
0.87
1.9
9.21
12.84
4.81
Investments
0
0
0
0
0
0
0
0
0
0
0
21.91
Other Assets
21.67
22.08
19.59
27.91
25.24
28.55
27.15
26.44
32.26
47.55
42.15
28.69
Total Assets
41.43
45.66
51.12
59.51
55.32
63.69
79.52
122
123
137
143
178
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.25
8.81
-5.66
11.11
-0.78
8.61
14.18
16.64
14.83
15.52
11.83
—
Investing
-2.04
-7.2
-11.84
-4.72
-3.53
-10.23
-22.82
-51.11
-4
-7.95
-15.84
—
Financing
-0.89
-0.32
6.83
-3.43
0.72
2.09
8.78
35.02
-11.18
-7.56
3.9
—
Net Cash Flow
-0.68
1.3
-10.67
2.96
-3.59
0.47
0.14
0.55
-0.34
0.01
-0.11
—
Free Cash Flow
0.21
1.61
-17.5
6.39
-4.31
-1.62
-8.64
-34.47
10.83
7.57
-4.01
—
CFO/OP
81
234
-70
110
-13
68
96
118
77
80
65
—
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88.43
48.79
82.03
91.48
54.98
69.11
51.39
85.37
86.52
94.76
87.98
80.42
Inventory Days
558
169
204
289
256
451
672
313
430
831
491
366
Days Payable
814
363
242
304
152
167
70.37
74.02
50.68
100
61.78
88
Cash Conversion Cycle
-168
-145
44.36
76.61
159
354
653
324
466
826
517
358
Working Capital Days
-354
-131
19.25
-13.28
36.22
35.15
28.76
8.1
38.09
63.76
100
-22.24
ROCE %
4.67%
5.98%
12.37%
15.18%
9.55%
13.82%
18.78%
9.29%
11.02%
9.94%
9.04%
7.29%

Shareholding Pattern

As of Jun 2026
Others 36.87%
Public 32.52%
Promoters 30.62%
Total 100.01%
  Mar 2021Apr 2021Jun 2021Sep 2021Dec 2021Mar 2022May 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025May 2025Jun 2025Aug 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
37.29%
39.30%
39.84%
39.84%
39.84%
39.67%
42.16%
42.16%
42.16%
42.16%
42.08%
42.08%
42.08%
42.08%
42.08%
42.08%
42.08%
38.88%
40.85%
43.36%
42.29%
39.06%
36.43%
35.16%
35.16%
35.43%
30.62%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
DIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
11.99%
10.78%
12.12%
12.85%
14.96%
20.66%
20.63%
20.78%
21.46%
22.99%
23.72%
23.86%
23.43%
23.52%
25.35%
26.11%
26.51%
35.03%
34.74%
33.27%
35.48%
34.39%
33.48%
32.30%
32.70%
32.37%
32.52%
Others
50.72%
49.92%
48.05%
47.32%
45.20%
39.67%
37.21%
37.07%
36.39%
34.85%
34.20%
34.06%
34.49%
34.40%
32.57%
31.81%
31.41%
26.08%
24.41%
23.37%
22.23%
26.55%
30.09%
32.53%
32.13%
32.20%
36.87%
No. of Shareholders
8,029
8,043
8,098
10,263
11,364
12,455
12,582
12,632
13,036
13,048
13,062
12,989
13,006
15,615
18,971
18,852
19,545
21,167
21,169
21,935
21,909
21,896
21,890
21,659
21,622
21,427
21,224

Documents

Frequently Asked Questions about Vivo Bio Tech Ltd

What does Vivo Bio Tech Ltd do?
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]
Where is Vivo Bio Tech Ltd (511509) listed?
Vivo Bio Tech Ltd is listed on the Indian stock exchanges. It is listed on NSE: VIVOBIOTECHLTD and BSE: VIVOBIOT. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Vivo Bio Tech Ltd belong to?
Vivo Bio Tech Ltd operates in the Healthcare sector within the Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a market capitalisation of approximately ₹51.94 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Vivo Bio Tech Ltd?
The Price-to-Earnings (PE) ratio of Vivo Bio Tech Ltd is -17.80. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Vivo Bio Tech Ltd?
Over the past 52 weeks, Vivo Bio Tech Ltd has traded between a low of ₹20.35 and a high of ₹43.35. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a Return on Equity (ROE) of 9.35%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Vivo Bio Tech Ltd on Tapetide?
On Tapetide, you can view Vivo Bio Tech Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]

Website vivobio.com
Face Value ₹ 10

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List